... of survival in patients with early stage disease[ 2,11,12 ] and new studies suggest a potential survival advantage ... all patients with invasive breast cancer. Axillary lymph node dissection (ALND) has now been replaced by sentinel lymph node biopsy (SLNB) for most patients with clinically ...
... is not necessary after mastectomy for DCIS. Invasive node-negative breast cancer In general, adjuvant ... whole-breast radiation is recommended for patients with node-negative disease who have undergone BCS as this approach ... risk of pneumonitis, which can develop anywhere from 4 to 12 weeks after radiation. This condition presents with ...
... The estimated risk for patients undergoing axillary lymph node dissection (ALND) is 20%, compared with 5% for sentinel lymph node biopsy (SLNB).[ 1 ] However, a more clinically ... lymphedema in patients with a history of skin puncture,[ 12 ] although recall bias has since been raised as an issue, ...
... largely accepted as the standard of care in patients with node-positive or high-risk node-negative breast cancer.[ 3 ] Currently, guidelines ... surgery 3 to 4 weeks after the last dose of chemotherapy.[ 12-14 ] Radiation was then offered to these patients based on ...